Hiroshi Takatani
- Co-authors
- Hiroshi SodaMinoru FukudaMikio OkaShigeru KohnoAkitoshi KinoshitaSeiji NagashimaYoichi NakamuraKenji Terashi
- Topics
- Lung Cancer Research Studies (22 papers)Cancer therapeutics and mechanisms (18 papers)Lung Cancer Treatments and Mutations (18 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshi Takatani
41 papers receiving 549 citations
Peers
Comparison fields: 5 of 70
- Oncology 382
- Molecular Biology 264
- Pulmonary and Respiratory Medicine 196
- Epidemiology 111
- Surgery 63
Countries citing papers authored by Hiroshi Takatani
This map shows the geographic impact of Hiroshi Takatani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Takatani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Takatani more than expected).
Fields of papers citing papers by Hiroshi Takatani
This network shows the impact of papers produced by Hiroshi Takatani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Takatani. The network helps show where Hiroshi Takatani may publish in the future.
Co-authorship network of co-authors of Hiroshi Takatani
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Takatani. A scholar is included among the top collaborators of Hiroshi Takatani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Takatani. Hiroshi Takatani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 27 | |
| 3 | 17 | |
| 4 | 46 | |
| 5 | 11 | |
| 6 | 12 | |
| 7 | 5 | |
| 8 | 16 | |
| 9 | 8 | |
| 10 | 24 | |
| 11 | 18 | |
| 12 | 11 | |
| 13 | 10 | |
| 14 | Multidrug resistance-associated protein gene expression and drug sensitivity in human lung cancer cells. | 12 |
| 15 | 1 | |
| 16 | 29 | |
| 17 | 23 | |
| 18 | 38 | |
| 19 | 42 | |
| 20 | 6 |
About Hiroshi Takatani
Hiroshi Takatani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 42 papers that have together received 559 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (22 papers), Cancer therapeutics and mechanisms (18 papers) and Lung Cancer Treatments and Mutations (18 papers). The work is most often cited by research in Oncology (382 citations), Pulmonary and Respiratory Medicine (196 citations) and Molecular Biology (264 citations). Hiroshi Takatani has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroshi Soda, Minoru Fukuda, Mikio Oka, Shigeru Kohno, Akitoshi Kinoshita, Seiji Nagashima, Yoichi Nakamura, Kenji Terashi, Kazuhiro Tsukamoto and Junji Tsurutani. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.